IndiaOne Finance - Company Dashboard

Governance Classic Home

Alivus Life Sciences LtdPharmaceuticalsINE03Q201024Standalone₹1431.10+44.05 (+3.18%)Jun-26

Valuation

Market Cap₹17.56K Cr

TTM PE29.13x

Forward PE27.86x

PEG4.28

Book Value₹271.48

P/B5.27x

TTM EPS₹49.12

Fwd EPS₹51.36

TTM Revenue₹2.59K Cr

TTM PAT₹603.03 Cr

TTM EBITDA₹836.70 Cr

TTM EBIT₹757.81 Cr

Last Qtr PAT₹160.08 Cr

Last Qtr EBITDA₹211.72 Cr

Last Qtr EBIT₹191.13 Cr

Profitability

ROE18.10%

ROCE24.00%

TTM NPM23.28%

TTM EBITDA %32.30%

Curr OPM24.15%

Last OPM22.85%

Curr NPM—

Last NPM—

Curr EPS₹13.04

Last EPS₹13.23

Balance sheet

Equity₹24.55 Cr

Reserve₹3.31K Cr

Total Debt₹56.77 Cr

D/E0.02x

Interest %0.82%

Curr Interest₹1.31 Cr

Price / range

Close₹1430.80

vs 52W High-4.22%

vs 52W Low+72.39%

MA50—

MA200—

Returns

1D+3.10%

1W+3.32%

1M+2.30%

3M+35.03%

6M+52.21%

1Y+51.13%

2Y+12.37%

3Y+121.43%

5Y—

Diwali+57.66%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	640.41+6.4%	689.12	672.89	587.98	601.85	2,551.83
Other Income	22.40	22.78	13.93	14.72	8.99	60.41
Total Income	662.82+8.5%	711.90	686.82	602.70	610.83	2,612.24
Interest	1.31	1.31	1.49	1.32	1.25	5.37
Expenditure	-450.59-0.6%	-496.10	-462.77	-428.56	-447.85	-1,835.28
PBDT	0	0	0	0	0	0
EBITDA	211.72+22.9%	214.53	231.27	179.18	172.31	797.28
Depreciation	-20.59	-20.20	-19.66	-18.44	-17.06	-75.36
EBIT	191.13+23.1%	194.33	211.61	160.74	155.25	721.92
PBT	212.22+30.2%	215.80	198.39	174.14	162.98	751.31
Tax	-52.15	-53.14	-48.13	-44.11	-41.45	-186.83
Equity	24.55	24.55	24.54	0	24.53	24.55
OPM	32.02	30.31	28.89	29.62	26.68	28.76
Net Profit	160.08+31.7%	162.66	150.26	130.03	121.54	564.48
NPM	24.15	22.85	21.88	22.11	19.90	21.61
EPS	13.04+31.6%	13.23	12.25	10.60	9.91	45.99

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	2,551.83+6.9%	2,386.88+4.5%	2,283.21+5.6%	2,161.22
Other Income	60.41	34.57	12.04	28.96
Total Income	2,612.24+7.9%	2,421.45+5.5%	2,295.26+4.8%	2,190.18
Expenditure	-1,835.28-3.8%	-1,767.32-6.2%	-1,663.97-6.6%	-1,561.57
Interest	-5.37	-2.41	-1.55	-0.55
PBDT	0	0	0	0
EBITDA	797.28+16.8%	682.58+1.2%	674.24+5.0%	642.29
Depreciation	-75.36	-60.61	-53.45	-42.09
EBIT	721.92+16.1%	621.97+0.2%	620.79+3.4%	600.20
PBT	751.31+14.9%	654.13+3.6%	631.29+0.4%	628.61
Tax	-186.83	-168.50	-160.40	-161.65
Equity	24.55	24.51	0	0
OPM (%)	28.76	27.01	28.00	29.00
Net Profit	564.48+16.2%	485.63+3.1%	470.89+0.8%	466.96
NPM (%)	21.61	20.06	21.00	21.00
EPS (Rs)	45.99+16.0%	39.63+3.1%	38.43+0.8%	38.11
CEPS	45.90	39.52	38.38	38.11

Metric	FY25-26
Revenue	2,551.83
Other Income	60.41
Total Income	2,612.24
Interest	5.37
Expenditure	-1,835.28
PBDT	0
EBITDA	797.28
Depreciation	-75.36
EBIT	721.92
PBT	751.31
Tax	-186.83
Equity	24.55
OPM	28.76
Net Profit	564.48
NPM	21.61
EPS	45.99

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	2,551.83+6.9%	2,386.88
Other Income	60.41	34.57
Total Income	2,612.24+7.9%	2,421.45
Expenditure	-1,835.28-3.8%	-1,767.32
Interest	-5.37	-2.41
PBDT	0	0
EBITDA	797.28+16.8%	682.58
Depreciation	-75.36	-60.61
EBIT	721.92+16.1%	621.97
PBT	751.31+14.9%	654.13
Tax	-186.83	-168.50
Equity	24.55	24.51
OPM (%)	28.76	27.01
Net Profit	564.48+16.2%	485.63
NPM (%)	21.61	20.06
EPS (Rs)	45.99+16.0%	39.63
CEPS	45.90	39.52

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	5	01 Sep 2026
2025	Final Dividend	5	01 Sep 2025
2024	Interim Dividend	22.5	17 Oct 2023
2023	Interim Dividend	21	24 Mar 2023

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split